Urosolv (1500 mg+250 mg)/5 ml (Oral Solution)
Medicine Details
Category | Details |
---|---|
Generic | Potassium citrate citric acid |
Company | Edruc limited |
Indications
- Relieves discomfort in urinary tract infections
- Prevents kidney stones
- Prevents gout with uricosuric agents
- Treats acidosis caused by kidney diseases
Pharmacology
Potassium Citrate and Citric Acid oral solution is a stable and pleasant-tasting oral systemic alkalizer. It alkalinizes the urine without producing a systemic alkalosis in recommended doses.
Dosage & Administration
- Relief of UTI:
- Adults and children over 6 years: 10 ml 3 times daily, diluted with 1 glass of water
- Children 1-6 years: 5 ml 3 times daily, diluted with ½ glass of water
- Prevention of kidney stones, gout, kidney disease acidosis:
- Adults: 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water
- Pediatric: 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water
Interaction
Concurrent administration of potassium-containing medication, potassium-sparing diuretics, ACE inhibitors, or cardiac glycosides may lead to toxicity.
Contraindications
Severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage, hyperkalemia from any cause
Side Effects
Generally well tolerated, caution in patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis. Potassium intoxication causes listlessness, weakness, mental confusion, tingling of extremities, and other symptoms associated with high serum Potassium concentration.
Pregnancy & Lactation
No information available regarding use during pregnancy and lactation.
Precautions & Warnings
Use caution in patients with low urinary output, dilute adequately with water, take each dose after meals. Large doses may cause hyperkalemia and alkalosis, especially in the presence of renal disease.
Overdose Effects
Can cause serious hyperkalemia, must be treated immediately. Treatment measures include elimination of potassium-containing foods or medications, intravenous administration of dextrose solution containing insulin, use of exchange resins, hemodialysis, or peritoneal dialysis.
Therapeutic Class
- Prevention of repeated kidney stone formation
- Urinary Alkalinizing Agent
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Related Brands
- Ureca (1500 mg+250 mg)/5 ml (Oral Solution) - general-pharmaceuticals-ltd
- Lyco (1500 mg+250 mg)/5 ml (Oral Solution) - alkad-laboratories
- Urifine (1500 mg+250 mg)/5 ml (Oral Solution) - novatek-pharmaceuticals-ltd
- Uri-K (1500 mg+250 mg)/5 ml (Oral Solution) - benham-pharmaceuticals-ltd
- Alcasol (1500 mg+250 mg)/5 ml (Oral Solution) - aci-limited